Literature DB >> 26424722

The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary.

Ronald Boellaard1.   

Abstract

The use of (18)F-FDG PET/CT as a quantitative imaging biomarker requires standardization and harmonization of imaging procedures and PET/CT system performance to obtain repeatable and reproducible quantitative data. However, a PET/CT system optimized to meet international quantitative standards is not necessarily optimized for use as a diagnostic tool (i.e. for lesion detectability). Several solutions have been proposed and validated, but until recently none of them had been implemented commercially. Vendor-provided solutions allowing the use of PET/CT both as a diagnostic tool and as a quantitative imaging biomarker are therefore greatly needed and would be highly appreciated. In this invited perspective one such solution is highlighted.

Entities:  

Keywords:  Biomarker; Image quality; PET; Quantification

Mesh：

Substances：

Year:  2016        PMID： 26424722     DOI： 10.1007/s00259-015-3182-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


  30 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

Review 2.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

3.  Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies.

Authors:  Linda M Velasquez; Ronald Boellaard; Georgia Kollia; Wendy Hayes; Otto S Hoekstra; Adriaan A Lammertsma; Susan M Galbraith
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

4.  Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.

Authors:  John J Sunderland; Paul E Christian
Journal:  J Nucl Med       Date:  2014-12-18       Impact factor: 10.057

5.  Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.

Authors:  Michael M Graham; Richard L Wahl; John M Hoffman; Jeffrey T Yap; John J Sunderland; Ronald Boellaard; Eric S Perlman; Paul E Kinahan; Paul E Christian; Otto S Hoekstra; Gary S Dorfman
Journal:  J Nucl Med       Date:  2015-04-16       Impact factor: 10.057

6.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

Review 7.  Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

Authors:  Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Frans H M Corstens; Wim J G Oyen
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

8.  18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Authors:  Geraldine Gebhart; Cristina Gámez; Eileen Holmes; Javier Robles; Camilo Garcia; Montserrat Cortés; Evandro de Azambuja; Karine Fauria; Veerle Van Dooren; Gursel Aktan; Maria Antonia Coccia-Portugal; Sung-Bae Kim; Peter Vuylsteke; Hervé Cure; Holger Eidtmann; José Baselga; Martine Piccart; Patrick Flamen; Serena Di Cosimo
Journal:  J Nucl Med       Date:  2013-10-03       Impact factor: 10.057

9.  Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

Authors:  Charline Lasnon; Cédric Desmonts; Elske Quak; Radj Gervais; Pascal Do; Catherine Dubos-Arvis; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

10.  SUVref: reducing reconstruction-dependent variation in PET SUV.

Authors:  Matthew D Kelly; Jerome M Declerck
Journal:  EJNMMI Res       Date:  2011-08-18       Impact factor: 3.138
View more
  3 in total

1.  Recent Survey of Effective Doses of F-18 FDG Torso PET/CT in Korea and the Current Recommendations for CT Protocols of PET/CT.

Authors:  Ari Chong; Jung Mi Park; Kyoungjune Pak; Yong-Il Kim; Hyun Woo Kwon; Eun Seong Lee; Ki Pyo Nam; Ho-Young Lee; Hong Jae Lee; Ik Dong Yoo; Jae Seon Eo; Ji Young Kim; Joon-Kee Yoon; Kyeong Min Kim; Seong Min Kim; Tae-Sung Kim
Journal:  Nucl Med Mol Imaging       Date:  2020-07-20

2.  Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria.

Authors:  Joke Devriese; Laurence Beels; Alex Maes; Christophe Van de Wiele; Hans Pottel
Journal:  EJNMMI Phys       Date:  2018-12-07

3.  Evaluation of PET quantitation accuracy among multiple discovery IQ PET/CT systems via NEMA image quality test.

Authors:  Delphine Vallot; Elena De Ponti; Sabrina Morzenti; Anna Gramek; Anna Pieczonka; Gabriel Reynés Llompart; Jakub Siennicki; Paul Deak; Chiranjib Dutta; Jorge Uribe; Olivier Caselles
Journal:  EJNMMI Phys       Date:  2020-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.